• Toggle Accessibility Statement
  • Home
  • Skip to Main Content
  • Sitemap
Menu
GOVPH
  • Home
  • About Us
    • The Pharmaceutical Division
  • Our Programs
    • COVID 19
    • Medicines Access
      • Active Drug Safety Monitoring and Management (aDSM) Program
    • Medicines Policy and Research
      • Advisory Council for the Implementation of RA 9502
      • Policy Dialogue on Universal Healthcare and Access to Medicines
      • Progress Report for the Implementation of the Cheaper Medicines Act of 2008
      • Research Management
    • Drug Pricing
      • Maximum Retail Price of Drugs and Medicines
      • Drug Price Database
      • Price Negotiation Board
      • Mark-up Regulation of Essential Medicines in DOH Facilities
    • Suggested Retail Price (SRP) for Selected Essential Emergency Medicines and Medical Devices
    • Botika ng Bayan and Botika ng Bayani
    • Rational Use of Medicines
      • Philippine National Formulary
      • DOH Program on Combating Antimicrobial Resistance
    • Medical Device
      • Philippine Essential Medical Device List
  • Documents and Issuances
    • Laws
    • Official Issuances
    • Researches and Publications
    • Progress Report
    • Drug Price Reference Index Booklet
  • Media Gallery
  • Links
  • AUXILIARY MENU
  • GOVPH
  • Home
  • About Us
    • The Pharmaceutical Division
  • Our Programs
    • COVID 19
    • Medicines Access
      • Active Drug Safety Monitoring and Management (aDSM) Program
    • Medicines Policy and Research
      • Advisory Council for the Implementation of RA 9502
      • Policy Dialogue on Universal Healthcare and Access to Medicines
      • Progress Report for the Implementation of the Cheaper Medicines Act of 2008
      • Research Management
    • Drug Pricing
      • Maximum Retail Price of Drugs and Medicines
      • Drug Price Database
      • Price Negotiation Board
      • Mark-up Regulation of Essential Medicines in DOH Facilities
    • Suggested Retail Price (SRP) for Selected Essential Emergency Medicines and Medical Devices
    • Botika ng Bayan and Botika ng Bayani
    • Rational Use of Medicines
      • Philippine National Formulary
      • DOH Program on Combating Antimicrobial Resistance
    • Medical Device
      • Philippine Essential Medical Device List
  • Documents and Issuances
    • Laws
    • Official Issuances
    • Researches and Publications
    • Progress Report
    • Drug Price Reference Index Booklet
  • Media Gallery
  • Links
    • Accessibility Statement
    • High Contrast
    • Skip to Content
    • Skip to Footer

Drug Price Reference Index (Frequently Asked Questions)

  • admin
  • January 16, 2021
  • 1:30 pm

Related Posts

  • Drug Price Reference Index

    07 Oct 2020
  • Electronic Drug Price Monitoring System

    21 Sep 2020
  • Maximum Retail Price of Drugs and Medicines

    14 Sep 2020
January 2021
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
« Dec   Feb »
PrevPreviousValue Added Tax (VAT) Exempt Sales of Drugs and Medicines Prescribed for Diabetes, Hypertension and High Cholesterol Under Train Law
NextSuggested Retail Price for Essential Medicines and Medical Devices (Frequently Asked Questions)Next

Philippine Standard time

Contact Us:

Telephone Number: 02-8757734 Loc. 253

Address: 4th Floor, Philippine Blood Center, Lung Center Compound, Quezon Avenue, Quezon City

Email Address: dohncpam@gmail.com

Related Links:

Drug Price Reference Index (DPRI)

Inter-agency Committee on Antimicrobial Resistance (ICAMR)

Drug Price Watch (DPW)

Health Technology Assessment Unit (HTAU)

Related Links (For DOH Personnel only):

Electronic Drug Price Monitoring System (EDPMS)

Pharmaceutical Management Information System (PMIS)